Erasca, Inc. financial data

Symbol
ERAS on Nasdaq
Location
10835 Road To The Cure, Suite 140, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.23K % +3.87%
Debt-to-equity 17.7 % -27.6%
Return On Equity -36.6 % +5.85%
Return On Assets -31.1 % +0.45%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 283M shares +87%
Common Stock, Shares, Outstanding 283M shares +87.3%
Entity Public Float 563M USD +89.5%
Common Stock, Value, Issued 28K USD +86.7%
Weighted Average Number of Shares Outstanding, Basic 283M shares +87.4%
Weighted Average Number of Shares Outstanding, Diluted 283M shares +87.4%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 41.1M USD +6.67%
Operating Income (Loss) -176M USD -23%
Nonoperating Income (Expense) 18.8M USD +13.8%
Net Income (Loss) Attributable to Parent -158M USD -24.2%
Earnings Per Share, Basic -1 USD/shares +32.1%
Earnings Per Share, Diluted -1 USD/shares +32.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 70.5M USD -8.14%
Marketable Securities, Current 234M USD +5.95%
Cash, Cash Equivalents, and Short-term Investments 305M USD +2.32%
Assets, Current 315M USD +2.61%
Property, Plant and Equipment, Net 15.6M USD -27%
Operating Lease, Right-of-Use Asset 31.5M USD -15.2%
Other Assets, Noncurrent 2.62M USD -41.3%
Assets 471M USD +27.4%
Accounts Payable, Current 2.26M USD -14.1%
Liabilities, Current 25.5M USD -15.8%
Operating Lease, Liability, Noncurrent 46M USD -9.43%
Other Liabilities, Noncurrent 251K USD -55.1%
Liabilities 71.7M USD -12.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 628K USD
Retained Earnings (Accumulated Deficit) -799M USD -24.6%
Stockholders' Equity Attributable to Parent 400M USD +38.5%
Liabilities and Equity 471M USD +27.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.6M USD +5.1%
Net Cash Provided by (Used in) Financing Activities 6.93M USD +3687%
Net Cash Provided by (Used in) Investing Activities 34.3M USD +244%
Common Stock, Shares Authorized 800M shares 0%
Common Stock, Shares, Issued 283M shares +87%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.74M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 70.9M USD -8.1%
Deferred Tax Assets, Valuation Allowance 180M USD +25.2%
Deferred Tax Assets, Gross 190M USD +21.7%
Operating Lease, Liability 50.8M USD -7.51%
Payments to Acquire Property, Plant, and Equipment 83K USD +97.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -157M USD -23.9%
Lessee, Operating Lease, Liability, to be Paid 69.6M USD -11.3%
Property, Plant and Equipment, Gross 26.4M USD -10.7%
Operating Lease, Liability, Current 4.79M USD +16.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.2M USD +0.32%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.17M USD +1.62%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 18.7M USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.28M USD +0.85%
Deferred Tax Assets, Operating Loss Carryforwards 70.1M USD +18.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 80M shares 0%
Unrecognized Tax Benefits 5.41M USD +32.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.57M USD +3.18%
Operating Lease, Payments 1.5M USD -28.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 3.63M USD -5.4%
Share-based Payment Arrangement, Expense 26.8M USD +2.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%